Text Box.

The author’s top 10 ‘suggested reading’ relevant to pharmacoepidemiological studies of drug-cancer associations (in non-prioritized order)

#	Authors	Title	Topic	Citation
01	Walker	For drug-induced carcinogenesis, the observations are the hypothesis. Invited editorial for the Mini-Symposium on Cancer Pharmacoepidemiology	Basic concepts	Ann Epidemiol 2016; 26(11):749–750
02	Pinheiro et al.	Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety	Basic concepts	Ann Epidemiol 2016; 26(11):735–740
03	Friis et al.	European Code against Cancer 4th edition: Medical exposures, including hormone therapy, and cancer	Basic concepts	Cancer Epidemiol 2015; 29 Suppl 1:S107–19
04	Rivera et al.	Connections between pharmacoepidemiology and cancer biology: designing biologically relevant studies of cancer outcomes	Exposure ascertainment	Ann Epidemiol 2016; 26(11):741–745
05	Pottegård & Hallas	New use of prescription drugs prior to a cancer diagnosis	Reverse causation	Pharmacoepidemiol Drug Saf 2017;26(2):223–227
06	Umar et al.	Future directions in cancer prevention	Cancer biology	Nat Rev Cancer 2012; 12 (12): 835–848
07	Rothman	Induction and latent periods	Induction/latency	Am J Epidemiol 1981; 114(2):253–9
08	Pottegård et al.	Identification of associations between prescribed medications and cancer: a nationwide screening study	Hypothesis generation	EBioMedicine 2016;7:73–9
09	Lund et al.	The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application	The active comparator, new user design	Curr Epidemiol Rep 2015; 2(4):221–228
10	Stürmer et al.	Adjustments for unmeasured confounders in pharmacoepidemiological database studies using external information	Advanced confounder adjustment	Med Care 2007; 45(10 Supl 2):S158–98